Analyze Diet

Topic:Diphtheria

Diphtheria in horses is a bacterial infection caused by Corynebacterium species, which can affect the respiratory system of equines. Although less common in horses compared to other species, diphtheria can lead to respiratory distress and other health complications. The infection is characterized by the formation of a pseudomembrane in the upper respiratory tract, which can obstruct airflow and cause breathing difficulties. Diagnosis typically involves clinical examination and laboratory tests to identify the presence of the bacteria. Treatment may include antibiotics and supportive care to manage symptoms. This page compiles peer-reviewed research studies and scholarly articles that investigate the occurrence, pathogenesis, and management of diphtheria in equine populations.
Pastern dermatitis outbreak associated with toxigenic and non-toxigenic Corynebacterium diphtheriae and non-toxigenic Corynebacterium ulcerans at a horse stable in Finland, 2021.
Zoonoses and public health    November 5, 2023   Volume 71, Issue 2 127-135 doi: 10.1111/zph.13090
Grönthal TSC, Lehto AK, Aarnio SS, Eskola EK, Aimo-Koivisto EM, Karlsson T, Koskinen HI, Barkoff AM, He Q, Lienemann T, Rimhanen-Finne R, Mykkänen A.Corynebacterium diphtheriae and Corynebacterium ulcerans, when producing toxin, are the cause of diphtheria, a potentially life-threatening illness in humans. Horses (Equus ferus caballus) are known to be susceptible to infection that may manifest clinically on rare occasions. In late 2021 and early 2022, specimens from five horses suffering from pastern dermatitis were cultured at the Laboratory of Clinical Microbiology at the Faculty of Veterinary Medicine, University of Helsinki, Finland. C. diphtheriae and/or C. ulcerans were recovered from all of these. This study aimed to (1) analyse the...
Corynebacteria of the diphtheriae Species Complex in Companion Animals: Clinical and Microbiological Characterization of 64 Cases from France.
Microbiology spectrum    April 6, 2023   Volume 11, Issue 3 e0000623 doi: 10.1128/spectrum.00006-23
Museux K, Arcari G, Rodrigo G, Hennart M, Badell E, Toubiana J, Brisse S.Corynebacteria of the diphtheriae species complex (CdSC) can cause diphtheria in humans and have been reported from companion animals. We aimed to describe animal infection cases caused by CdSC isolates. A total of 18,308 animals (dogs, cats, horses, and small mammals) with rhinitis, dermatitis, nonhealing wounds, and otitis were sampled in metropolitan France (August 2019 to August 2021). Data on symptoms, age, breed, and the administrative region of origin were collected. Cultured bacteria were analyzed for tox gene presence, production of the diphtheria toxin, and antimicrobial susceptibili...
Clinical Serum Therapy: Benefits, Cautions, and Potential Applications.
The Keio journal of medicine    April 28, 2017   Volume 66, Issue 4 57-64 doi: 10.2302/kjm.2016-0017-IR
Hifumi T, Yamamoto A, Ato M, Sawabe K, Morokuma K, Morine N, Kondo Y, Noda E, Sakai A, Takahashi J, Umezawa K.Blood serum from immunized humans or animals (e.g., horses) contains relevant antibodies and has been used as serum therapy to treat many diseases or envenomation events. The effectiveness of blood serum was initially discovered in 1890 when Kitasato and von Behring observed the effectiveness of this type of therapy against diphtheria and tetanus. Serum therapies played an important role in the advancement of modern medicine prior to the development of penicillin and steroids. At present, several types of serum therapy remain in clinical use. However, some physicians have a limited understandi...
Development of human monoclonal antibodies to diphtheria toxin: A solution for the increasing lack of equine DAT for therapeutic use?
Virulence    May 19, 2016   Volume 7, Issue 6 613-615 doi: 10.1080/21505594.2016.1190062
Huygen K.No abstract available
Structural and antigenic features of the synthetic SF23 peptide corresponding to the receptor binding fragment of diphtheria toxin.
Molecular immunology    July 23, 2014   Volume 63, Issue 2 235-244 doi: 10.1016/j.molimm.2014.07.008
Khrustaleva TA, Khrustalev VV, Barkovsky EV, Kolodkina VL, Astapov AA.The SF23 peptide corresponding to the receptor binding fragment of diphtheria toxin (residues 508-530) has been synthesized. This fragment forming a protruding beta hairpin has been chosen because it is the less mutable B-cell epitope. Affine chromatography and ELISA show that antibodies from the sera of persons infected by toxigenic Corynebacterium diphtheriae and those immunized by diphtheria toxoid are able to bind the synthetic SF23 peptide. There are antibodies recognizing the SF23 peptide in the serum of horses hyperimmunized with diphtheria toxoid. Analysis of circular dichroism spectra...
Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication.
Infection and immunity    August 12, 2013   Volume 81, Issue 11 3992-4000 doi: 10.1128/IAI.00462-13
Sevigny LM, Booth BJ, Rowley KJ, Leav BA, Cheslock PS, Garrity KA, Sloan SE, Thomas W, Babcock GJ, Wang Y.Diphtheria antitoxin (DAT) has been the cornerstone of the treatment of Corynebacterium diphtheriae infection for more than 100 years. Although the global incidence of diphtheria has declined steadily over the last quarter of the 20th century, the disease remains endemic in many parts of the world, and significant outbreaks still occur. DAT is an equine polyclonal antibody that is not commercially available in the United States and is in short supply globally. A safer, more readily available alternative to DAT would be desirable. In the current study, we obtained human monoclonal antibodies (h...
BERNA: a century of immunobiological innovation.
Vaccine    October 3, 1999   Volume 17 Suppl 2 S1-S5 doi: 10.1016/s0264-410x(99)00228-5
Cryz SJ.At the time the Swiss Serum and Vaccine Institute Berne (BERNA) was found in 1898, few vaccines or immune globulins were available. This short list included vaccines against cholera, typhoid fever, plague, smallpox and rabies and equine anti-tetanus and diphtheria immune globulins. Furthermore, their use was restricted due to limited production capacity, uncertainty regarding safety and no public health infrastructure to promote their utilization. Today, safe and effective vaccines exist for more than 30 infectious diseases while human hyperimmune globulins exist to treat or prevent rabies, te...
Heterologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis.
Annals of internal medicine    August 1, 1996   Volume 125, Issue 3 233-236 doi: 10.7326/0003-4819-125-3-199608010-00012
Wilde H, Thipkong P, Sitprija V, Chaiyabutr N.Active immunization against infectious disease is important. However, much of our world faces poverty, social injustice, and warfare, all of which cause universal immunization to remain a distant dream. Agents that provide passive immunity thus remain essential biologicals. The most important of these are human or equine antisera against rabies, tetanus, diphtheria, and snake antivenins. Homologous products are either unavailable or unaffordable in places where they are needed the most. Less expensive heterologous (equine) antisera can be purified and are safe to use, but these antisera are al...
Dynamic changes of horse serum T-globulin immunization with snake venoms, tetanus and diphtheria toxoids.
Zhonghua Minguo wei sheng wu xue za zhi = Chinese journal of microbiology    December 1, 1979   Volume 12, Issue 4 127-135 
Lee HF, Lee JD, Lee YC.In course of immunizing horses with snake venoms, tetanus and diphtheria toxoids, a new serum component, T-globulin, was formed and migrated between the beta- and gamma-globulins. The T-globulin content was parallel with the antibody titre after the middle course of immunization. There were many components in snake antivenin and T-globulin was composed of most of those components. The components of diphtheria T-globulin were the same as those of crude antitoxin and tetanus T-globulin except one precipitin.
Carbohydrate oxidation and antibody function in equine anti-diphtheria immunoglobulin T.
Immunochemistry    October 1, 1975   Volume 12, Issue 10 795-800 doi: 10.1016/0019-2791(75)90142-1
Buchowicz I, Zakrzewski K.No abstract available
Appearance of pre-alpha-2-globulins soon after the very first dose of diphtheria toxoid in horse.
Experientia    March 15, 1966   Volume 22, Issue 3 167-168 doi: 10.1007/BF01897714
Acharya US, Rao SS.No abstract available
Studies on horse antibodies. I. Development of antibody in different fractions of serum during immunization of horse with diphtheria toxoid.
Indian journal of biochemistry    March 1, 1966   Volume 3, Issue 1 33-37 
Acharya US, Rao SS.No abstract available
The effect of injection on diphtheria prophylactic into apparently normal horses.
British journal of experimental pathology    October 1, 1950   Volume 31, Issue 5 615-625 
BARR M.No abstract available
The Quantitative Changes in the Proteins in the Blood Plasma of Horses in the Course of Immunization.
The Journal of experimental medicine    May 1, 1910   Volume 12, Issue 3 411-434 doi: 10.1084/jem.12.3.411
Gibson RB, Banzhaf EJ.Gravimetric determinations were recorded for the total and several individual proteins (in the sodium oxalate plasma) fractioned with ammonium sulphate and sodium chloride. At precipitation, the plasma salt mixture had been diluted to a final volume of ten times the amount of plasma employed. Coagulations were on aliquot portions of filtrates, and the individual protein constituents (except serumalbumin) were calculated by difference. The eleven horses had been subjected to simultaneous immunization against diphtheria and tetanus toxins, each horse being subsequently continued on the toxin to ...
Comparative Statistics of Antitoxin Horses: A Study of the Records of One Hundred Horses Immunized to Diphtheria Toxin, with Composite of Curves.
The Journal of experimental medicine    April 25, 1905   Volume 7, Issue 2 176-182 doi: 10.1084/jem.7.2.176
Hubbert WR.1. Better results in the production of diphtheria antitoxin can be obtained with greater experience in the selection of the most suitable type of horses to be used. Young animals are usually to be preferred. Over one-half of all such horses can be made to yield 300-unit serum, while a third will yield (5)oo-unit serum. 2. High-test horses require a shorter time to immunize and will yield a potent serum for a longer period than will low-test horses. 3. The period of usefulness of an antitoxin horse is short, and on an average endures only a few months. 4. A horse having attained a maximal antit...